Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Obesity (Silver Spring). 2022 Jun 29;31(Suppl 1):50–56. doi: 10.1002/oby.23451

Table 1:

Comparison of body fat, melatonin, energy intake, and the time to pass caloric midpoint (average time at which 50% of daily calories were consumed) relative to different outcome variables in individuals with a lean or overweight/obesity body composition.”

Lean (n=55) Overweight/obesity (n=32) p-value
Body Fat
All (%, SEM) 16.5 (0.8) 32.0 (1.1) p<0.0001
Male (%, SEM) 14.5 (0.6) 25.2 (1.0) p<0.0001
Female (%, SEM) 24.0 (1.2) 33.8 (1.0) p<0.001
Melatonin
In-Laboratory DLMO (hh:mm, SEM) 23:25 (00:13) 22:59 (00:17) p=0.23
Model 1: Light and Activity pDLMO (hh:mm, SEM) 22:55 (00:19) 23:06 (00:17) p=0.69
Model 2: Activity pDLMO (hh:mm, SEM) 22:55 (00:20) 22:51 (00:17) p=0.90
Food Timing and Energy Intake
Caloric Midpoint Clock Time (hh:mm, SEM) 16:08 (00:20) 16:41 (00:23) p=0.30
Caloric Midpoint Relative to DLMO (h, SEM) −7.4 (0.3) −6.2 (0.3) p<0.01
Caloric Midpoint Relative to Light and Activity pDLMO (h, SEM) −6.9 (0.3) −6.3 (0.3) p=0.23
Caloric Midpoint Relative to Activity pDLMO (h, SEM −6.9 (0.4) −6.1 (0.4) p=0.12
Daily Energy Intake (kcal, SEM) 1672.3 (68.4) 1658.7 (84.0) p=0.90
Kaplan-Meier Survival Log-Rank tests
Clock time of caloric midpoint (HR, 95% CI) 0.8 (0.5 to 1.2) p=0.32
In-Laboratory DLMO (HR, 95% CI) 2.4 (1.4 to 4.0) p=0.001
Sleep Onset (HR, 95% CI) 1.3 (0.8 to 2.1) p=0.25
Sleep Offset (HR, 95% CI) 0.8 (0.5 to 1.2) p=0.22
Model 1: Light and Activity pDLMO (HR, 95% CI) 1.8 (1.1 to 2.9) p=0.02
Model 2: Activity pDLMO (HR, 95% CI) 1.6 (1.0 to 2.7) p=0.045

SEM, standard error of the mean; DLMO, dim-light melatonin onset; pDLMO, predicted dim-light melatonin onset; HR, Hazard Ratio; CI, Confidence Interval